重型COVID-19有创机械通气患者炎症细胞因子水平变化分析
该回顾性研究纳入2020年2月4日至3月25日武汉协和医院收治的43例重型COVID-19有创机械通气患者,记录插管前48小时、插管后48小时及脱机后48小时或死亡前的IL-2、IL-4、IL-6、IL-10、TNF-α水平。13例好转、30例死亡;死亡组年龄更大、高血压/糖尿病/冠心病比例更高、发病至入院/入ICU/插管时间更长。死亡组插管后48小时IL-6和TNF-α较插管前及存活组显著升高,IL-6为住院死亡独立危险因素。
要点
- 死亡组死亡前IL-10为55.89(26.07, 100.14)ng/L,存活组脱机后48小时为3.53(2.76, 12.36)ng/L,死亡组显著升高(P<0.05)。
- 多因素Logistic回归显示IL-6(OR=0.902,95%CI 0.819-0.994)为住院死亡独立危险因素(P<0.05)。
- IL-2和IL-4在各时间点两组间无显著差异。
适用人群与场景
- 2020年2月4日至3月25日武汉协和医院收治的重型COVID-19有创机械通气患者43例。
- 排除标准原文未提及。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:回顾性研究;样本量43例(存活13例,死亡30例);单中心(武汉协和医院);人群为重型COVID-19有创机械通气患者。
- 死亡组较存活组年龄更大(67.6±7.3 vs 58.5±11.9岁,P<0.05),高血压、糖尿病、冠心病比例更高(53.3% vs 15.4%、63.3% vs 23.1%、26.7% vs 0%,均P<0.05),发病至入院、入ICU、插管时间更长(9.17±5.00 vs 5.07±2.49天、17.10±7.11 vs 12.23±5.05天、17.90±7.46 vs 12.61±5.60天,均P<0.05)。
- 死亡组死亡前IL-10较存活组脱机后48小时显著升高[55.89(26.07, 100.14)vs 3.53(2.76, 12.36)ng/L,P<0.05]。
- IL-2和IL-4各时间点两组间无显著差异。
- 多因素Logistic回归:年龄(OR=0.821,95%CI 0.695-0.968)、高血压(OR=0.027,95%CI 0.002-0.378)、糖尿病(OR=0.054,95%CI 0.005-0.611)、冠心病(OR=0.042,95%CI 0.002-0.968)、插管后IL-6(OR=0.902,95%CI 0.819-0.994)为住院死亡独立危险因素(均P<0.05)。
证据类型、等级与局限
- 证据类型:回顾性研究;证据等级原文未提及。
- 局限性:原文未述局限性。
对床旁实践的改变
- 对重型COVID-19有创机械通气患者,插管后48小时IL-6升高可能提示住院死亡风险增加,可考虑动态监测IL-6。
- 年龄、高血压、糖尿病、冠心病等基础疾病与住院死亡风险相关,临床评估时应纳入考虑。
指南或共识出处
- Zhonghua Wei Zhong Bing Ji Jiu Yi Xue(中华危重病急救医学)发表的回顾性研究,标题:Analysis of the changes of inflammatory cytokine levels in patients with critical coronavirus disease 2019 undergoing invasive mechanical ventilation.
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the relationship between the changes of inflammatory cytokine levels and prognosis of patients with critical coronavirus disease 2019 (COVID-19) undergoing invasive mechanical ventilation (IMV).
METHODS: A retrospective study was conducted. The clinical date of critical COVID-19 patients undergoing IMV who were hospitalized in Wuhan Union Hospital, Tongji Medical College of Huazhong University of Science and Technology from February 4th to March 25th in 2020 were collected. At the same time, the inflammatory cytokine levels including interleukins (IL-2, IL-4, IL-6, IL-10) and tumor necrosis factor-α (TNF-α) at 48 hours before IMV and 48 hours after IMV of all the patients, as well as the 48 hours after weaning or right before death were recorded. Multivariate unconditional Logistic regression analysis was used to screen the independent risk factors of death during hospitalization.
RESULTS: Among the 43 patients, 13 patients improved and 30 died. Compared with the survival group, the patients in the non-survival group were older (years old: 67.6±7.3 vs. 58.5±11.9, P < 0.05), with higher rates of hypertension, diabetes and coronary heart disease (53.3% vs. 15.4%, 63.3% vs. 23.1%, 26.7% vs. 0%, all P < 0.05), and the time from onset to admission to hospital, admission to ICU and IMV were longer (days: it was 9.17±5.00 vs. 5.07±2.49, 17.10±7.11 vs. 12.23±5.05, and 17.90±7.46 vs. 12.61±5.60, respectively, all P < 0.05). The IL-6 and TNF-α levels on 48 hours after IMV in the non-survival patients increased significantly as compared with those before 48 hours and the surviving patients. Especially, the IL-6 levels increased significantly as compared with those at 48 hours after IMV and 48 hours after weaning in the surviving patients [ng/L: 800.00 (194.25, 2 000.00) vs. 22.03 (6.66, 28.21), 3 204.00 (1 264.88, 5 000.00) vs. 5.00 (3.98, 12.27), both P < 0.01]. The IL-10 level before death in the non-survival patients increased significantly as compared with that at 48 hours after weaning in the surviving patients [ng/L: 55.89 (26.07, 100.14) vs. 3.53 (2.76, 12.36), P < 0.05]. There were no significant differences in the levels of IL-2 and IL-4 between the two groups at every time point. The variables of age, basic diseases, the IL-6 level after IMV were included in the multivariate unconditional Logistic regression analysis, which showed that age [odds ratio (OR) = 0.821, 95% confidence interval (95%CI) was 0.695-0.968], hypertension (OR = 0.027, 95%CI was 0.002-0.378), diabetes mellitus (OR = 0.054, 95%CI was 0.005-0.611), coronary heart disease (OR = 0.042, 95%CI was 0.002-0.968) and the IL-6 level after IMV (OR = 0.902, 95%CI was 0.819-0.994) were independent risk factors for death during hospitalization in patients with critical COVID-19 undergoing IMV (all P < 0.05).
CONCLUSIONS: The levels of inflammatory cytokine including IL-6, IL-10, and TNF-α increased significantly with aggravation in critical COVID-19 patients undergoing IMV, especially IL-6. IL-6 was an independent risk factor for death of critical COVID-19 patients undergoing IMV.
参考来源
- Shan H, Lyu Z, Xiao Y, et al. [Analysis of the changes of inflammatory cytokine levels in patients with critical coronavirus disease 2019 undergoing invasive mechanical ventilation]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 33081889. doi:10.3760/cma.j.cn121430-20200414-00519
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。